Sequential Bacillus Calmette Guèrin and electromotive mitomycin-C versus Bacillus Calmette Guèrin alone for high-risk superficial bladder cancer: A prospective controlled study

Controlled Study ◽

Sequential Bacillus Calmette Guèrin and electromotive mitomycin-C versus Bacillus Calmette Guèrin alone for high-risk superficial bladder cancer: A prospective controlled study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4539 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4539-4539 ◽

Cited By ~ 1

Author(s):

S. M. Di Stasi ◽

A. Giannantoni ◽

R. L. Stephen ◽

G. Capelli ◽

A. Giurioli ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Controlled Study ◽

489 Sequential intravesical bacillus Calmette-Guèrin and electromotive mitomycin-C for high risk superficial bladder cancer: A prospective controlled study

European Urology Supplements ◽

10.1016/s1569-9056(04)90486-1 ◽

2004 ◽

Vol 3 (2) ◽

pp. 125

Author(s):

S.M. Di Stasi ◽

A. Giannantoni ◽

R. Stephen ◽

G. Capelli ◽

A. Giurioli ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Controlled Study ◽

830: Sequential Bacillus Calmette-Guèrin and Electromotive Mitomycin-C Versus Bacillus Calmette Guèrin Alone for High Risk Superficial Bladder Cancer: Long-Term Follow-Up Results of a Prospective Controlled Study

10.1016/s0022-5347(18)33066-0 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 268-268 ◽

Cited By ~ 3

Author(s):

Savino M. Di Stasi ◽

Antonella Giannantoni ◽

Arcangelo Giurioli ◽

Giuseppe Vespasiani ◽

Germano Zampa ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Controlled Study ◽

Long Term Follow Up ◽

280: Sequential Intra Vesical Bacillus Calmette Guerin and Electromotive Mitomycin-C for High Risk Superficial Bladder Cancer: A Prospective Controlled Study

10.1016/s0022-5347(18)37542-6 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 74-74 ◽

Cited By ~ 2

Author(s):

Savino M. Di Stasi ◽

Antonella Giannantoni ◽

Robert L. Stephen ◽

Guido Virgili ◽

Arcangelo Giurioli ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Controlled Study ◽

LONG-TERM FOLLOW-UP OF A RANDOMISED TRIAL COMPARING SEQUENTIAL BACILLUS CALMETTE-GUÈRIN AND ELECTROMOTIVE MITOMYCIN-C WITH BACILLUS CALMETTE GUÈRIN ALONE IN HIGH-RISK SUPERFICIAL BLADDER CANCER

European Urology Supplements ◽

10.1016/s1569-9056(06)60679-9 ◽

2006 ◽

Vol 5 (2) ◽

pp. 191 ◽

Cited By ~ 1

Author(s):

S.M. Di Stasi ◽

A. Giannantoni ◽

A. Giurioli ◽

G. Vespasiani ◽

G. Zampa ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Randomised Trial ◽

Long Term Follow Up

Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials

BJU International ◽

10.1111/j.1464-410x.2003.04655.x ◽

2004 ◽

Vol 93 (4) ◽

pp. 485-490 ◽

Cited By ~ 195

Author(s):

M.D. Shelley ◽

T.J. Wilt ◽

J. Court ◽

B. Coles ◽

H. Kynaston ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Randomized Trials ◽

Meta Analysis ◽

Tumour Recurrence ◽

Bacillus Calmette Guerin

1570: Combined Mitomycin C and Hyperthermia (SYNERGO) for Patients with Superficial Bladder Cancer (SBC) after Bacillus Calmette-Guerin (BCG) Failure

10.1016/s0022-5347(18)31758-0 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 519-519

Author(s):

Ofer Nativ ◽

Renzo Colombo ◽

Dov Engelstein ◽

Ofer N. Gofrit ◽

Thomas Akkad ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Bcg Failure

A Randomized Multicenter Trial of Adjuvant Therapy in Superficial Bladder Cancer: Transurethral Resection Only Versus Transurethral Resection Plus Mitomycin C Versus Transurethral Resection Plus Bacillus Calmette-Guerin

10.1016/s0022-5347(01)65673-8 ◽

1996 ◽

Vol 156 (3) ◽

pp. 962-966 ◽

Cited By ~ 131

Author(s):

S. Krege ◽

G. Giani ◽

R. Meyer ◽

T. Otto ◽

H. Rubben

Keyword(s):

Bladder Cancer ◽

Adjuvant Therapy ◽

Mitomycin C ◽

Transurethral Resection ◽

Multicenter Trial ◽

Bacillus Calmette Guerin

Re: Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C versus bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer

10.1016/j.juro.2018.06.043 ◽

2018 ◽

Vol 200 (4) ◽

pp. 696-697

Author(s):

Sam S. Chang

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Randomised Controlled Trial ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

Randomised Controlled

PD19-07 ONE-YEAR FOLLOW-UP RESULTS AFTER SEQUENTIAL INTRAVESICAL BACILLUS CALMETTE-GUÉRIN AND DEVICE-ASSISTED CHEMO-HYPERTHERMIA (MITOMYCIN C DELIVERED BY THE COMBAT BRS SYSTEM) FOR HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS...A BACILLUS CALMETTE-GUÉRIN-SPARING STRATEGY

10.1016/j.juro.2017.02.880 ◽

2017 ◽

Vol 197 (4S) ◽

Cited By ~ 1

Author(s):

TR Leyshon Griffiths ◽

William JF Green ◽

Peter T Grice ◽

Jonathan C Goddard ◽

Roger C Kockelbergh

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Cancer Patients ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Muscle Invasive ◽

One Year